Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208871 · ClinicalTrials.gov registry record · NA
An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 1,467
- Enrollment target
NCT00208871 is a NA study that has completed, run by Emory University. The registered enrollment target is 1,467 participants.
The verdict
NCT00208871, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,467 participants
- Enrollment target
Study Summary
The primary goal of this study is to compare, within a clinical screening setting, the performance of stereoscopic digital mammography with standard (non-stereo) digital mammography in the detection of abnormalities in the breast, including early breast cancer.
Interventions
- PROCEDURE Stereoscopic Digital Mammography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,467 participants |
| Start Date | 2004-12 |
| Est. Completion | 2011-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208871
The ClinicalTrials.gov registry entry for NCT00208871 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,467 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereoscopic Digital Mammography is the first listed.
NCT00208871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208871 about?
NCT00208871 is a clinical study titled "An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall". The primary goal of this study is to compare, within a clinical screening setting, the performance of stereoscopic digital mammography with standard (non-stereo) digital mammography in the detection of abnormalities in the breast, including early breast cancer.
What is the current status of trial NCT00208871?
This trial is currently completed. It is a NA study. The enrollment target is 1,467 participants. The study started on 2004-12. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00208871?
The interventions under investigation include: Stereoscopic Digital Mammography (PROCEDURE).
Who is sponsoring clinical trial NCT00208871?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.